Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Exclusive manufacturer-reported metrics
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

orthopedicpress release
Market Scope Announces Launch of New Website and Entry into Orthopedics

Market Scope, an industry leader for ophthalmic market research, announced today the launch of its new website and the firm’s entry into orthopedics, its second medical vertical. The new Market-Sco...

Akorn Looks for New CEO after Latest Court Loss over Fresenius Deal

Akorn Pharmaceuticals announced Dec. 7 that it was searching for a new CEO following another legal defeat in the company’s fight to salvage its deal with Fresenius Kabi. The Supreme Court of the St...

AGTC Drops Gene Therapy Program for X-Linked Retinoschisis

AGTC will drop its gene therapy program for X-linked retinoschisis (XLRS) following interim six-month data from a Phase I/II study, the company announced Dec. 12. The trial has been investigating r...

Atia Vision Raises $10 Million in Series C to Advance Accommodating IOL

Atia Vision of Campbell, California, reported Dec. 10 that it closed the second tranche of a Series C preferred stock financing Nov. 9, raising a total of $10 million. The company is developing a m...

Alimera Sciences Names Rick Eiswirth as CEO

Alimera Sciences announced Nov. 29 that Rick Eiswirth will take over Jan. 2 as chief executive officer. Eiswirth, who has served as the company’s president for three years, also will join the board...

OCTANe Names Mazzo Board Chair

Orange Country Technology Alliance’s (OCTANe) has named James Mazzo as its chair. Mazzo will assume the post for two years beginning Jan. 1. Mazzo is the global president of ophthalmic devices at C...

Rejoint Completes YourKnee Testing

Rejoint announced the completion of mechanical testing for its YourKnee implant on Nov. 30. YourKnee is a cobalt chrome 3D-printed system for TKA that uses AI to custom-fit each patient. The first ...

Zimmer Stimulator Recall

The US FDA announced on Nov. 27 that Zimmer Biomet initiated a Class I recall of its OsteoGen Implantable Bone Growth Stimulator, SpF Plus-Mini Implantable Fusion Stimulator, and SpF-XL Implantable...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

US Surveys
May select more than one
Outside of US Surveys